Investing to become financially independent
Investing to become financially independent
Discover an in-depth analysis of Swiss companies offering attractive dividends, beyond the traditional SMI Blue Chips. The article explores different selection criteria, including dividend growth and regularity of payments, to identify the best investment opportunities in terms of returns.
Discover an in-depth analysis of Swiss SMI companies that offer attractive and regular dividends for investors. The article examines in detail the performance of large companies such as Nestlé, Roche, Swisscom and Syngenta, while assessing their reliability and potential for an investment strategy based on growing dividends.
SMI and growing dividends (by Jean-Louis – guest member) Read More »
bioMérieux, a world leader in microbiology and in vitro diagnostics, offers innovative solutions for the detection of infectious diseases and food safety. The French company, with a century of family expertise, is expanding internationally while maintaining a growth-oriented strategy in emerging fields such as molecular biology, offering a stable stock profile despite a moderate return.
A common mistake investors make is to focus solely on high dividend yields, ignoring the potential risks of dividend cuts or elimination. Find out why it makes more sense to focus on companies like Novo Nordisk, IBM and Roche, which offer sustainable and consistent dividend growth rather than just high yields.
In the face of the dollar's devaluation, we have so far taken a number of measures that are certainly useful, but insufficient. Indeed, we have to admit that our performance is weighed down by the strength of the CHF, whereas with the euro as our reference currency, the picture is quite different. As we are focusing on revenues, and as
Illinois Tool Works (ITW), an industrial giant with over 85 years of consecutive dividend increases, stands out for its targeted acquisition strategy and international presence. The company, operating in eight different sectors, has solid fundamentals despite sensitivity to the US dollar, making it a stock to watch closely for investors.
The first decade of the 21st century was marked by high stock market volatility, with the S&P making dramatic highs and lows. Learn how to navigate this volatile market and how to invest in more stable stocks that pay consistent dividends, including consumer and healthcare sectors.
Discover Roche, the Swiss pharmaceutical giant, world leader in cancer treatment and virology, with flagship products such as Valium and Tamiflu. The group offers an attractive yield of 3.24% and a sustained growth of its dividends, making it an interesting investment despite a higher volatility than its competitors.
Français